Related Experiment Video
Updated: Jan 7, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
[Priapism associated with atomoxetine use]
Atomoxetine, used for attention-deficit/hyperactivity disorder (ADHD), can cause priapism (painful erections) in adults. Discontinuing the medication resolved the side effect, emphasizing vigilance in adult patients.
Area of Science:
- Pharmacology
- Urology
- Psychiatry
Background:
- Atomoxetine is a selective norepinephrine reuptake inhibitor used to treat attention-deficit/hyperactivity disorder (ADHD).
- Priapism, a prolonged and painful erection, is a rare but serious side effect associated with certain medications.
Purpose of the Study:
- To report a case of atomoxetine-induced priapism in an adult male.
- To highlight the importance of considering priapism as a potential side effect of atomoxetine in adult patients.
Main Methods:
- Case report of a 33-year-old male patient treated with atomoxetine for ADHD.
- Clinical observation of side effects and patient-reported symptoms.
- Discontinuation of atomoxetine and monitoring for resolution of priapism.
Main Results:
- The patient developed intermittent priapism while taking atomoxetine.
- Discontinuation of atomoxetine led to the spontaneous resolution of painful erections.
- This case adds to existing literature on atomoxetine-induced priapism, previously reported mainly in pediatric populations.
Conclusions:
- Atomoxetine can cause priapism in adult patients, not exclusively in children and adolescents.
- Healthcare providers should maintain vigilance for priapism as a potential adverse effect of atomoxetine in all age groups.
- Early recognition and discontinuation of the drug can lead to spontaneous resolution of this complication.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Antidepressant Drugs: MAOIs and Other Agents
Drugs Affecting Neurotransmitter Release or Uptake
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...

